Loading clinical trials...
Loading clinical trials...
A Multicenter, Non-interventional, Post-authorization Study to Observe in Daily Clinical Practice the Treatment Duration of Patients Treated With Avastin (Bevacizumab) in 1st Line mCRC in Belgium
Conditions
Interventions
bevacizumab [Avastin]
Locations
19
Belgium
Aalst, Belgium
Antwerp, Belgium
Assebroek, Belgium
Aye, Belgium
Bruges, Belgium
Brussels, Belgium
Start Date
January 1, 2010
Primary Completion Date
June 1, 2013
Completion Date
June 1, 2013
Last Updated
December 16, 2015
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06607458
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions